Losartan Potassium And Hydrochlorothiazide
Product Images NDC 68258-6040

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Losartan Potassium And Hydrochlorothiazide (NDC 68258-6040). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 68258-6040-xx (Ndc 68258 6040 Xx Zydus)

Ndc 68258-6040-xx (Ndc 68258 6040 Xx        Zydus)
This is a product description of Losartan Potassium/HCTZ XX (100 mg/25 mg*) Tablets. The tablets are white to off-white and are film-coated, capsule-shaped, and have ZD19 written on them. They are distributed by Zydus Pharmaceuticals USA Inc. and the product ID is 6040-X. These tablets are dispensed orally, and patients should take ___ tablet(s) ___ time(s) a day as directed by their physician. The MFR. LOT number is not given. The product is packed in a tight/light-resistant container, and patients should not discontinue usage without a physician's advice. Dizziness or drowsiness may occur. The tablets contain 100 mg of Losartan Potassium USP and 25 mg of Hydrochlorothiazide USP. A warning is given that use during pregnancy can cause fetal harm, and it is marked RX only. The tablets should be kept out of children's reach and stored between 68°- 77° F. The packaged by address is Santa Ana, CA 92704.*
FDA Label Image

Structured Formula For Losartan (Losartan Hydro Figure 01)

FDA Label Image

Structured Formula For Losartan (Losartan Hydro Figure 02)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.